263 related articles for article (PubMed ID: 33603125)
1. A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis.
Liu W; Tian J; Hui W; Kong W; Feng Y; Si J; Gao F
Sci Rep; 2021 Feb; 11(1):4143. PubMed ID: 33603125
[TBL] [Abstract][Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
3. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
6. [ANALYSIS OF THE RESULTS OF ENDOSCOPIC AND MORPHOLOGICAL STUDIES OF THE STOMACH MUCOSA WITH REDUCED PEPSINOGEN-I IN PATIENTS WITH H. PYLORI (H.P.)--ASSOCIATED GASTRITIS IN TOMSK AND TOMSK REGION].
Beloborodova EV; Purlik IL; Li NA; Rachkovskiy MI; Sanzharovskaya MS
Eksp Klin Gastroenterol; 2015; (4):66-70. PubMed ID: 26415268
[TBL] [Abstract][Full Text] [Related]
7. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
Kitamura Y; Yoshihara M; Ito M; Boda T; Matsuo T; Kotachi T; Tanaka S; Chayama K
J Gastroenterol Hepatol; 2015 Oct; 30(10):1473-7. PubMed ID: 25974661
[TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
10. Relationship between ghrelin,
Ichikawa H; Sugimoto M; Sakao Y; Sahara S; Ohashi N; Kato A; Sugimoto K; Furuta T; Andoh A; Sakao T; Yasuda H
World J Gastroenterol; 2016 Dec; 22(47):10440-10449. PubMed ID: 28058025
[TBL] [Abstract][Full Text] [Related]
11. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
12. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
[TBL] [Abstract][Full Text] [Related]
14. Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis.
Lahner E; Vaira D; Figura N; Pilozzi E; Pasquali A; Severi C; Perna F; Delle Fave G; Annibale B
Helicobacter; 2004 Oct; 9(5):436-42. PubMed ID: 15361083
[TBL] [Abstract][Full Text] [Related]
15. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.
Veijola LI; Oksanen AM; Sipponen PI; Rautelin HI
World J Gastroenterol; 2010 Jan; 16(1):83-8. PubMed ID: 20039453
[TBL] [Abstract][Full Text] [Related]
16. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
18. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis.
Annibale B; Di Giulio E; Caruana P; Lahner E; Capurso G; Bordi C; Delle Fave G
Aliment Pharmacol Ther; 2002 Oct; 16(10):1723-31. PubMed ID: 12269964
[TBL] [Abstract][Full Text] [Related]
19. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
20. Type I and type II
Yuan L; Zhao JB; Zhou YL; Qi YB; Guo QY; Zhang HH; Khan MN; Lan L; Jia CH; Zhang YR; Ding SZ
World J Gastroenterol; 2020 Jul; 26(25):3673-3685. PubMed ID: 32742135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
